Case of parvovirus B19 infection and immunodeficiency in the patient with Gilbert syndrome

A case of long-term persistence of parvovirus B19 is described for the first time in a patient with Gilbert's syndrome against the background of immunodeficiency with predominance of infectious symptoms (chronic herpesvirus infection). Previously, the patient (male, 48 years old) was diagnosed with Gilbert's syndrome, chronic rhinosinusopharyngitis, and chronic herpesvirus infection. In July 2017, parvovirus B19 DNA was detected in blood. No clinical manifestations of infectious erythema were noted. The patient was admitted to the medical center of St. Petersburg Pasteur Institute. His blood samples obtained under informed consent were examined at the medical center in Central Clinical and Diagnostic Laboratory of St. Petersburg Pasteur Institute in January and June 2018 and in November 2019. ELISA test systems “Anti-Parvovirus B19 ELISA (IgM)” and “Anti-Parvovirus B19 ELISA (IgG)” (Euroimmune, Germany), as well PCR reagent kit “AmpliSens Parvovirus B19-FL” (FSB Central Research Institute of Epidemiology of Rospotrebnadzor, Russia) were used for specific diagnostics. Interferon status was determined by the induced production of IFN types I, II and circulating (serum) interferons. Moreover, we considered the laboratory data obtained earlier at different medical facilities of St. Petersburg. IgM class antibodies to the parvovirus B19 were not detected in the blood samples obtained in 2018. IgG antibody titer was 96 IU/ml and 264 IU /ml, respectively. Parvovirus B19 DNA was isolated from blood plasma, but the viral load was less than 720 IU of PVB19 DNA/ml (1.5 x 10² and 1.9 x 10² copies of DNA/ml, respectively). Clinical blood analysis, showed only minor (no more than 7%) deviations from the reference values, increased hemoglobin saturation of red blood cells (RBC), a decreased width of RBC distribution curve, and relative lymphocytosis. A deficiency of various interferon types was revealed: IFNγ level was 80 IU/ml in both samples, IFNα, IFNβ amounts varied from 80 to 160 IU/ml, respectively. The period of parvovirus B19 DNA persistence in blood was 11 months in presence of immunodeficiency. The patient was administered drugs of the interferon group. Parvovirus B19 DNA was not detected in clinical samples of November 2019; IFNα, IFNβ and IFNγ values were 160 IU/ml. We have detected recovery of lymphoid cell ratio, increase in their number, and improved indexes of interferon status.

1. № Авторы, названиепубликациииисточника, выходныеданные ФИО, названиепубликациииисточниканаанглийском Полный интернет-адрес (URL) статьи или её doi.

2. Антипова А.Ю., Лаврентьева И.Н., Бичурина М.А., Семенов А.В. Лабораторная диагностика парвовирусной инфекции в системе эпидемиологического надзора за экзантемными заболеваниями // Эпидемиология и вакцинопрофилактика.-2012.- Т. 2, № 63.- С. 26-29. AntipovaA.Yu., LavrentievaI.N., BitchourinaM.A., SemyonovA.V.Laboratory diagnostics of parvovirus B19 infection in exanthematous diseases surveilliance. Epidemiology and Vaccinal Prevention,2012, Vol. 2, no. 63, pp. 26-29.(In Russ.) https://elibrary.ru/item.asp?id=17677505

3. Викулов Г.Х. Иммунологические аспекты герпес-вирусных инфекций // Клиническая дерматология и венерология. – 2015.- Т. 5.- С. 104-114. Vikulov G.KH. Immunological Aspects of Herpesvirus Infections. The russian journal of clinical dermatology and venereology, 2015, Vol. 5, pp. 104-114. (In Russ.) https://www.mediasphera.ru/issues/klinicheskaya-dermatologiya-i-venerologiya/2015/5/downloads/ru/171997-284920150517

4. Doi: 10.17116/klinderma2015145104-114

5. Лаврентьева И.Н., Антипова А.Ю., Бичурина М.А., Никишов О.Н., Железнова Н.В., Кузин А.А. Выявление случаев парвовирусной инфекции в системе эпидемиологического надзора за экзантемными заболеваниями // Инфекция и иммунитет.- 2016.- Т. 6, № 3.- С. 219-224. Lavrentyeva I.N., AntipovaA.Yu., Bichurina M.A., Nikishov O.N., Zheleznova N.V., Kuzin A.A. Detection of cases of parvovirus infection in the system for epidemiological surveillance of exanthematic diseases. Russian Journal of Infection and Immunity. 2016, Vol. 6, no. 3, pp. 219-224. (In Russ.) https://doi.org/10.15789/2220-7619-2016-3-219-224

6. Нестерова И.В. Врожденные и приобретенные интерферонопатии: дифференцированные подходы к интерферон-корректирующей терапии // Детские инфекции.- 2017.- T.16, № 2.- С. 50-53. Nesterova I.V. Congenital and acquired interferonopathies: differentiated approaches to the interferon-corrective therapy. children infections. 2017,Vol.16, no. 2, pp. 50-53. (In Russ.) https://doi.org/10.22627/2072-8107-2017-16-2-50-53

7. DOI:10.22627/2072-8107-2017-16-2-50-53.

8. Никишов О.Н., Кузин А.А., Антипова А.Ю., Лаврентьева И.Н. Парвовирусная инфекция - современная проблема в эпидемиологии и клинической медицине // Эпидемиология и вакцинопрофилактика.- 2015.- Т. 4, № 83.- С. 29-35. Nikishov O.N., Kuzin A.A., AntipovaA.Yu., Lavrent’eva I.N. Parvovirus Infection – Contemporary Issues in Epidemiology and Clinical Medicine. Epidemiology and Vaccinal Prevention, 2015, Vol. 14, no. 4, pp. 29-35. (In Russ.) https://doi.org/10.31631/2073-3046-2015-14-4-29-35

9. Определение интерферонового статуса как метод оценки иммунореактивности при различных формах патологии. Пособие для врачей. - М., СПб: 2002.- 25 с. Determination of interferon status as a method for assessing immunoreactivity in various forms of pathology. Manual for doctors. Moscow, Saint Petersburg, 2002, 25 p. (In Russ.)

10. Рейзис А.Р. Синдром Жильбера. Современные воззрения, исходы и терапия. /Internist.ru – Всероссийская Образовательная Интернет-Программа для Врачей: Гепатология: [электронный ресурс]. Reizis A.R. Gilbert syndrome. Modern views, outcomes, and therapy. /Internist.ru -All-Russian Educational Internet Program for Doctors: Hepatology: [electronic resource] (InRuss.) https://internist.ru/publications/detail/sindrom-zhilbera.-sovremennye-vozzreniya,-ishody-i-terapiya/

11. Сологуб Т.В. Ледванов М.Ю. Малый В.П. Стукова Н.Ю. Романцов М.Г. Бизенкова М.Н. Полякова Т.Д. Иммунный ответ при вирусных инфекциях // Успехи современного естествознания.- 2009.- Т.12.- С. 29-33. Sologub T. V. Ledvanov M. Yu. Maly V. P. Stukova N. Yu. Romantsov M. G. Bizenkova M. N. Polyakova T. D. Immune response in viral infections. Advances in current natural sciences, 2009, Vol. 12, pp. 29-33. (In Russ.) https://natural-sciences.ru/ru/article/view?id=14061

12. Corcioli F., Zakrzewska K., Rinieri A., Fanci R., Innocenti M., Civinini R., De Giorgi V, Di Lollo S., Azzi A. Tissue Persistence of Parvovirus B19 Genotypes in Asymptomatic Persons. Journal of Medical Virology, 2008, Vol. 80, pp. 2005–2011. - http://fondazionebartolomeicorsi.it/files/Corcioli-et-al---2008--Journal-Medical-Virology_fez46mjv.pdf

13. Gama B.E., Emmel V.E., Oliveira-Silva M., Gutiyama L.M., Arcuri L., Colares M., Tavares R. de C., Bouzas L.F., Abdelhay E., Hassan R. Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients. Transplant Direct., 2017, Vol. 3, no. 11, pp. e217. - doi:10.1097/TXD.0000000000000731. https://pubmed.ncbi.nlm.nih.gov/29184906/

14. Jon B., Suzich A.R. Cliffe Strength in diversity: Understanding the pathways to herpes simplex virus reactivation. Virology, 2018, Vol. 522, pp. 81–91 -

15. Khamitova I.V., Lavrentyeva I.N., Averyanova M.Y., Chukhlovin A.B., Zubarovskaya L.S., Afanasyev B.V. Parvovirus B19 incidence, specific antibody response, and delayed hematopoietic recovery after allogeneic hematopoietic stem cell transplantation. CellularTherapyandTransplantation, 2018, Vol. 7, no.1, pp.36-43. -

16. Naciute M., Mieliauskaite D., Rugiene R., Maciunaite G., Mauricas M., Murovska M., Girkontaite I. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients. Cytokine, 2017, Vol. 96, pp. 41–48. -

17. Rosato P.C., Leib D.A. Neurons versus herpes simplex virus: the innate immune interactions that contribute to a host-pathogen standoff. FutureVirol., 2015, Vol. 10, no.6, pp. 699–714. - doi: 10.2217/fvl.15.45

18. Wua J., Chena X., Yea H., Yaoa M., Lia Sh., Chen L. Nonstructural protein (NS1) of human parvovirus B19 stimulates hostinnate immunity and blunts the exogenous type I interferon signaling in vitro. Virus Research, 2016, Vol. 222, pp. 48–52. -